Related content

Core binding factor acute myeloid leukaemia and c-KIT mutations

By                          

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1867-1872

Spandidos Publications

Access to resources Recommend Favorite

Acute myeloid leukemia with monosomy 20 and diabetes insipidus: a possible novel association

By Beyar Katz Ofrat  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1547-1551

Informa Healthcare

Access to resources Recommend Favorite

Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature

By Krstovski Nada   Tosic Natasa   Janic Dragana   Dokmanovic Lidija   Kuzmanovic Milos   Spasovski Vesna   Pavlovic Sonja  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 640-645

Humana Press, Inc

Access to resources Recommend Favorite

Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs

By Fiegl Michael  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 2, 2008-07 ,pp. : 321-329

Springer Publishing Company

Access to resources Recommend Favorite

The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 341-351

Bentham Science Publishers

Access to resources Recommend Favorite